Skip to main content
. 2016 Mar 31;6:23689. doi: 10.1038/srep23689

Figure 4. Effector cells expressing KIR2DL2/L3-E35 showed stronger inhibition than those with KIR2DL2/L3-Q35 allele in vivo.

Figure 4

YT-Indy cell line expressing different KIR2DL2/L3-E35, -Q35 or mutant alleles were injected in NSG mice with 721.221 target cells expressing HLA-Cw7 ligand and luciferase. (A) Bioluminescence pictures of mice after two weeks of injection. (B) Comparison of average bioluminescence signals among different groups of mice injected with YT-Indy cells carrying different KIR2DL2/L3 alleles. P values were calculated using Student T test. Error bars represent SD.